tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

PolyNovo Expands Global Reach with Innovative Wound Management Solutions

Story Highlights
PolyNovo Expands Global Reach with Innovative Wound Management Solutions

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Polynovo ( (AU:PNV) ) has shared an announcement.

PolyNovo’s 2025 Annual Report highlights its strategic focus on expanding global reach and product offerings, particularly with NovoSorb MTX. The company is enhancing its market position by scaling operations and driving growth through innovation, which is expected to benefit stakeholders by improving patient outcomes and increasing market penetration.

The most recent analyst rating on (AU:PNV) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Polynovo stock, see the AU:PNV Stock Forecast page.

More about Polynovo

PolyNovo, headquartered in Melbourne, Australia, is a medical technology company specializing in the management of acute and complex wounds. The company offers innovative product solutions such as NovoSorb BTM and NovoSorb MTX, which enhance patient outcomes across a wide range of wounds. PolyNovo has treated over 84,000 patients in 46 countries and is expanding its global presence through new products and clinical indications.

YTD Price Performance: -25.25%

Average Trading Volume: 2,666,783

Technical Sentiment Signal: Hold

Current Market Cap: A$1.05B

Find detailed analytics on PNV stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1